Oxidative stress is predominant in female but not in male patients with autoimmune thrombocytopenia

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Kamhieh Milz, Julian ^a   Salama, Abdulgabar ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT CAPACITY; CURRENT DIAGNOSTICS; GENDER-SPECIFIC DIFFERENCES; HEALTHY CONTROLS; HEALTHY INDIVIDUALS; POSITIVE CORRELATIONS; RELIABLE MEASUREMENT; THROMBOCYTOPENIA;

OXYGEN; SURVEYS;

ASSAYS;

OXYGEN RADICAL; ANTIOXIDANT;

ADULT; ARTICLE; AUTOIMMUNE THROMBOCYTOPENIA; BODY HEIGHT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIET; DISEASE COURSE; FEMALE; FOOD INTAKE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LIFESTYLE; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; OXIDATIVE STRESS; QUESTIONNAIRE; SEX DIFFERENCE; STRESS; THROMBOCYTE COUNT; WELLBEING; BLOOD; CASE CONTROL STUDY; DEMOGRAPHY; METABOLISM; PATHOLOGY;

ADULT; ANTIOXIDANTS; CASE-CONTROL STUDIES; DEMOGRAPHY; FEMALE; HUMANS; MALE; OXIDATIVE STRESS; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; QUESTIONNAIRES;

EID: 84893194820     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/720347     Document Type: Article

References (58)

1. George J. N., Woolf S. H., Raskob G. E., Wasser J. S., Aledort L. M., Ballem P. J., Blanchette V. S., Bussel J. B., Cines D. B., Kelton J. G., Lichtin A. E., McMillan R., Okerbloom J. A., Regan D. H., Warrier I., Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996 88 1 3 40 2-s2.0-8944225498 (Pubitemid 26230668)
2. Rodeghiero F., Stasi R., Gernsheimer T., Michel M., Provan D., Arnold D. M., Bussel J. B., Cines D. B., Chong B. H., Cooper N., Godeau B., Lechner K., Mazzucconi M. G., McMillan R., Sanz M. A., Imbach P., Blanchette V., Kuhne T., Ruggeri M., George J. N., Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009 113 11 2386 2393 2-s2.0-64049085194 10.1182/blood-2008-07-162503
3. Coopamah M. D., Garvey M. B., Freedman J., Semple J. W., Cellular immune mechanisms in autoimmune thrombocytopenic purpura: an update. Transfusion Medicine Reviews 2003 17 1 69 80 2-s2.0-0037228342 10.1053/tmrv.2003.50004 (Pubitemid 36042646)
4. Cines D. B., Bussel J. B., Liebman H. A., Luning Prak E. T., The ITP syndrome: pathogenic and clinical diversity. Blood 2009 113 26 6511 6521 2-s2.0-69249240344 10.1182/blood-2009-01-129155
5. Stasi R., Evangelista M. L., Stipa E., Buccisano F., Venditti A., Amadori S., Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management. Thrombosis and Haemostasis 2008 99 1 4 13 2-s2.0-38349190476 10.1160/TH07-08-0513
6. Salama A., Current treatment options for primary immune thrombocytopenia. Expert Review of Hematology 2011 4 1 107 118 2-s2.0-79951775524 10.1586/ehm.10.76
7. McMillan R., Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Seminars in Hematology 2000 37 3 239 248 2-s2.0-0033853833 (Pubitemid 30612902)
8. Kuwana M., Ikeda Y., The role of autoreactive T-cells in the pathogenesis of idiopathic thrombocytopenic purpura. International Journal of Hematology 2005 81 2 106 112 2-s2.0-13944266299 10.1532/IJH97.04176 (Pubitemid 40270981)
9. Bartosz G., Peroxynitrite: mediator of the toxic action of nitric oxide. Acta Biochimica Polonica 1996 43 4 645 659 2-s2.0-0030342473
10. Ischiropoulos H., Biological selectivity and functional aspects of protein tyrosine nitration. Biochemical and Biophysical Research Communications 2003 305 3 776 783 2-s2.0-0038731081 10.1016/S0006-291X(03)00814-3 (Pubitemid 36581936)
11. Ischiropoulos H., Gow A., Pathophysiological functions of nitric oxide-mediated protein modifications. Toxicology 2005 208 2 299 303 2-s2.0-13244284790 10.1016/j.tox.2004.11.018 (Pubitemid 40187339)
12. Patel R. P., McAndrew J., Sellak H., White C. R., Jo H., Freeman B. A., Darley-Usmar V. M., Biological aspects of reactive nitrogen species. Biochimica et Biophysica Acta 1999 1411 2-3 385 400 2-s2.0-0032953005 10.1016/S0005- 2728(99)00028-6 (Pubitemid 29221963)
13. Kannan S., Free radical theory of autoimmunity. Theoretical Biology and Medical Modelling 2006 3 article 22
14. Kurien B. T., Hensley K., Bachmann M., Scofield R. H., Oxidatively modified autoantigens in autoimmune diseases. Free Radical Biology and Medicine 2006 41 4 549 556 2-s2.0-33746033343 10.1016/j.freeradbiomed.2006.05.020 (Pubitemid 44080517)
15. Kurien B. T., Scofield R. H., Autoimmunity and oxidatively modified autoantigens. Autoimmunity Reviews 2008 7 7 567 573 2-s2.0-50949098933 10.1016/j.autrev.2008.04.019
16. Chou M.-Y., Fogelstrand L., Hartvigsen K., Hansen L. F., Woelkers D., Shaw P. X., Choi J., Perkmann T., Bäckhed F., Miller Y. I., Hörkkö S., Corr M., Witztum J. L., Binder C. J., Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. Journal of Clinical Investigation 2009 119 5 1335 1349 2-s2.0-66449085101 10.1172/JCI36800
17. Ohno Y., Kanoh T., Uchino H., Idiopathic thrombocytopenic purpura with defective oxidative metabolism of neutrophils. Acta Haematologica Japonica 1984 47 6 1257 1264 2-s2.0-0021126716 (Pubitemid 14010553)
18. Brox A. G., Howson-Jan K., Fauser A. A., Treatment of idiopathic thrombocytopenic purpura with ascorbate. British Journal of Haematology 1988 70 3 341 344 2-s2.0-0023796724 (Pubitemid 18265254)
19. Jubelirer S. J., Pilot study of ascorbic acid for the treatment of refractory immune thrombocytopenic purpura. American Journal of Hematology 1993 43 1 44 46 2-s2.0-0027221740 (Pubitemid 23134581)
20. Karduss Urueta A., Morales Polanco M. R., Pizzuto Chávez J., Meillón García L. A., Results of the treatment of chronic idiopathic thrombocytopenic purpura with ascorbic acid. Gaceta Medica de Mexico 1993 129 1 23 25 2-s2.0-0027353313
21. Vianelli N., Gugliotta L., Gianni L., Belmonte M. M., Catani L., Tura S., Ascorbic acid for the treatment of chronic refractory idiopathic thrombocytopenic purpura (ITP). Haematologica 1992 77 1 92 93 2-s2.0-0026574365
22. Akbayram S., Dogan M., Akgün C., Mukul Y., Peker E., Bay A., Çaksen H., Oner A. F., The association of oxidant status and antioxidant capacity in children with acute and chronic ITP. Journal of Pediatric Hematology/Oncology 2010 32 4 277 281 2-s2.0-77952781035 10.1097/MPH. 0b013e3181d6421f
23. Zhang B., Lo C., Shen L., Sood R., Jones C., Cusmano-Ozog K., Park-Snyder S., Wong W., Jeng M., Cowan T., Engleman E. G., Zehnder J. L., The role of vanin-1 and oxidative stress-related pathways in distinguishing acute and chronic pediatric ITP. Blood 2011 117 17 4569 4579 2-s2.0-79955955115 10.1182/blood-2010-09-304931
24. Polat G., Tamer L., Tanriverdi K., Gürkan E., Baslamisli F., Atik U., Levels of malondialdehyde, glutathione and ascorbic acid in idiopathic thrombocytopaenic purpura. East African Medical Journal 2002 79 8 446 449 2-s2.0-0036704654
25. Jin C. Q., Dong H. X., Cheng P. P., Zhou J. W., Zheng B. Y., Liu F., Antioxidant status and oxidative stress in patients with chronic ITP. Scandinavian Journal of Immunology 2013 77 482 487
26. Kamhieh-Milz J., Bal G., Sterzer V., Kamhieh-Milz S., Arbach O., Salama A., Reduced antioxidant capacities in platelets from patients with autoimmune thrombocytopenia purpura (ITP). Platelets 2012 23 3 184 194 2-s2.0-84859735884 10.3109/09537104.2011.610909
27. Neunert C., Lim W., Crowther M., Cohen A., Solberg L. Jr., Crowther M. A., The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011 117 16 4190 4207 2-s2.0-79955984501 10.1182/blood-2010-08-302984
28. Frederiksen H., Schmidt K., The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood 1999 94 3 909 913 2-s2.0-0033179664 (Pubitemid 29361821)
29. Schoonen W. M., Kucera G., Coalson J., Li L., Rutstein M., Mowat F., Fryzek J., Kaye J. A., Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database. British Journal of Haematology 2009 145 235 244 2-s2.0-70349220851 10.1111/j.1365-2141.2009.07896.x
30. Segal J. B., Powe N. R., Prevalence of immune thrombocytopenia: analyses of administrative data. Journal of Thrombosis and Haemostasis 2006 4 11 2377 2383 2-s2.0-33750061309 10.1111/j.1538-7836.2006.02147.x (Pubitemid 44575432)
31. Vassalle C., Maffei S., Boni C., Zucchelli G. C., Gender-related differences in oxidative stress levels among elderly patients with coronary artery disease. Fertility and Sterility 2008 89 3 608 613 2-s2.0-40249101603 10.1016/j.fertnstert.2007.03.052 (Pubitemid 351335031)
32. Kikuchi A., Takeda A., Onodera H., Kimpara T., Hisanaga K., Sato N., Nunomura A., Castellani R. J., Perry G., Smith M. A., Itoyama Y., Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy. Neurobiology of Disease 2002 9 2 244 248 2-s2.0-0036197296 10.1006/nbdi.2002.0466 (Pubitemid 34261218)
33. Schuessel K., Leutner S., Cairns N. J., Müller W. E., Eckert A., Impact of gender on upregulation of antioxidant defence mechanisms in Alzheimer's disease brain. Journal of Neural Transmission 2004 111 9 1167 1182 2-s2.0-4544354817 10.1007/s00702-004-0156-5 (Pubitemid 39222776)
34. Dreyer L., Prescott E., Gyntelberg F., Association between atherosclerosis and female lung cancer-a Danish cohort study. Lung Cancer 2003 42 3 247 254 2-s2.0-0344442374 10.1016/S0169-5002(03)00295-2 (Pubitemid 37474246)
35. Ortona E., Margutti P., Matarrese P., Franconi F., Malorni W., Redox state, cell death and autoimmune diseases: a gender perspective. Autoimmunity Reviews 2008 7 7 579 584 2-s2.0-51749121957 10.1016/j.autrev.2008.06.001
36. Nussinovitch U., Shoenfeld Y., The role of gender and organ specific autoimmunity. Autoimmunity Reviews 2012 11 6-7 A377 A385 2-s2.0-84858450790 10.1016/j.autrev.2011.11.001
37. Invernizzi P., Pasini S., Selmi C., Gershwin M. E., Podda M., Female predominance and X chromosome defects in autoimmune diseases. Journal of Autoimmunity 2009 33 1 12 16 2-s2.0-67349085696 10.1016/j.jaut.2009.03.005
38. Di Comite G., Grazia Sabbadini M., Corti A., Rovere-Querini P., Manfredi A. A., Conversation galante: how the immune and the neuroendocrine systems talk to each other. Autoimmunity Reviews 2007 7 1 23 29 2-s2.0-35448956094 10.1016/j.autrev.2007.03.004 (Pubitemid 47633388)
39. Lleo A., Battezzati P. M., Selmi C., Gershwin M. E., Podda M., Is autoimmunity a matter of sex? Autoimmunity Reviews 2008 7 8 626 630 2-s2.0-51749110645 10.1016/j.autrev.2008.06.009
40. Rubtsov A. V., Rubtsova K., Kappler J. W., Marrack P., Genetic and hormonal factors in female-biased autoimmunity. Autoimmunity Reviews 2010 9 7 494 498 2-s2.0-77951878126 10.1016/j.autrev.2010.02.008
41. Fairweather D., Rose N. R., Women and autoimmune diseases. Emerging Infectious Diseases 2004 10 11 2005 2011 2-s2.0-7644226154 (Pubitemid 39458572)
42. Poljsak B., Strategies for reducing or preventing the generation of oxidative stress. Oxidative Medicine and Cellular Longevity 2011 2011 15 2-s2.0-84855589344 10.1155/2011/194586 194586
43. Newton J. L., Reese J. A., Watson S. I., Vesely S. K., Bolton-Maggs P. H. B., George J. N., Terrell D. R., Fatigue in adult patients with primary immune thrombocytopenia. European Journal of Haematology 2011 86 5 420 429 2-s2.0-79954419462 10.1111/j.1600-0609.2011.01587.x
44. Tomic S., Brkic S., Maric D., Mikic A. N., Lipid and protein oxidation in female patients with chronic fatigue syndrome. Archives of Medical Science 2012 8 886 891
45. 2 and antioxidants have opposite effects on activation of NF- χ B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO Journal 1993 12 5 2005 2015 2-s2.0-0027269781 (Pubitemid 23157717)
46. Schreck R., Rieber P., Baeuerle P. A., Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF- B transcription factor and HIV-1. EMBO Journal 1991 10 8 2247 2258 2-s2.0-0025739254 (Pubitemid 21905698)
47. Kim S. J., Angel P., Lafyatis R., Hattori K., Kim K. Y., Sporn M. B., Karin M., Roberts A. B., Autoinduction of transforming growth factor β 1 is mediated by the AP-1 complex. Molecular and Cellular Biology 1990 10 4 1492 1497 2-s2.0-0025218491
48. Voigt A., Rahnefeld A., Kloetzel P. M., Kruger E., Cytokine-induced oxidative stress in cardiac inflammation and heart failure-how the ubiquitin proteasome system targets this vicious cycle. Frontiers in Physiology 2013 4 article 42
49. He B., Chadburn A., Jou E., Schattner E. J., Knowles D. M., Cerutti A., Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. Journal of Immunology 2004 172 3268 3279 2-s2.0-1842423767 (Pubitemid 38263719)
50. Pers J.-O., Daridon C., Devauchelle V., Jousse S., Saraux A., Jamin C., Youinou P., BAFF overexpression is associated with autoantibody production in autoimmune diseases. Annals of the New York Academy of Sciences 2005 1050 34 39 2-s2.0-23744476832 10.1196/annals.1313.004 (Pubitemid 41129420)
51. Moon E.-Y., Lee J.-H., Oh S.-Y., Ryu S.-K., Kim H.-M., Kwak H.-S., Yoon W.-K., Reactive oxygen species augment B-cell-activating factor expression. Free Radical Biology and Medicine 2006 40 12 2103 2111 2-s2.0-33745170431 10.1016/j.freeradbiomed.2006.02.007 (Pubitemid 43903097)
52. Tada F., Abe M., Kawasaki K., Miyake T., Shiyi C., Hiasa Y., Matsuura B., Onji M., B cell activating factor in obesity is regulated by oxidative stress in adipocytes. Journal of Clinical Biochemistry and Nutrition 2013 52 120 127
53. Emmerich F., Bal G., Barakat A., Milz J., Mühle C., Martinez-Gamboa L., Dörner T., Salama A., High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura. British Journal of Haematology 2007 136 2 309 314 2-s2.0-33845864446 10.1111/j.1365-2141.2006.06431.x (Pubitemid 46020761)
54. Cerella C., Coppola S., Maresca V., De Nicola M., Radogna F., Ghibelli L., Multiple mechanisms for hydrogen peroxide-induced apoptosis. Annals of the New York Academy of Sciences 2009 1171 559 563 2-s2.0-69149103207 10.1111/j.1749-6632.2009.04901.x
55. Rukoyatkina N., Walter U., Gambaryan S., NO inhibits platelet apoptosis by cGMP-dependent and-independent pathways. BMC Pharmacology 2009 9 article P60
56. Thachil J., Nitric oxide in immune thrombocytopenic purpura. Hematology 2009 14 1 59 62 2-s2.0-64949157090 10.1179/102453309X385151
57. Mason K. D., Carpinelli M. R., Fletcher J. I., Collinge J. E., Hilton A. A., Ellis S., Kelly P. N., Ekert P. G., Metcalf D., Roberts A. W., Huang D. C. S., Kile B. T., Programmed anuclear cell death delimits platelet life span. Cell 2007 128 6 1173 1186 2-s2.0-33947227522 10.1016/j.cell.2007.01.037 (Pubitemid 46427871)
58. Qi B., Hardwick J. M., A Bcl-xL timer sets platelet life span. Cell 2007 128 6 1035 1036 2-s2.0-33947236955 10.1016/j.cell.2007.03.002 (Pubitemid 46427881)